Recent Articles

IBB: This Biotech ETF Still Looks Short-Worthy

The market's turbulence really did a number on darlings like the biotech ETF, IBB. Traders should look to get short on the IBB. More 

The Best Way to Buy Biotech Stocks: A Heated Debate

Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers. More 

CELG Stock: Embrace the Biotech Boom With Celgene Calls

Celgene (CELG) stock is offering an attractive buying opportunity. Snatch up long CELG calls on the cheap to profit. More 

Soft Economic Data Can’t Hold Wall Street Back

Stocks won out on a low-volume Monday, though large caps returned to the middle of their sideways trading range. More 

Market Holds Big-Picture Support, but Will It Last?

The longer-term charts show the trend is still up. More 

Disney Dunks the Dow to Six-Month Lows

Wall Street is a graveyard for highfliers of late, with Disney (DIS), Tesla (TSLA) and Apple (AAPL) helping to pull the broader indices lower. More 

Nasdaq Sets New Highs as Greece Nears Exit

The Nasdaq reset its high-water mark on Thursday as post-Fed buying took hold. Now the onus is on the bulls to show they're going to follow through. More